Regression of left ventricular hypertrophy with isradipine antihypertensive therapy. 1993

G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
Department of Cardiology, University of Athens, Greece.

To assess left ventricular (LV) structural and functional changes, 45 hypertensive patients were studied by echocardiography after 2 weeks of placebo and 6 months of isradipine monotherapy. Although LV cavity size did not change, LV wall thickness decreased dramatically (P < .0001), producing a significant decrease in LV mass index (from 158 g/m2 to 136 g/m2; P < .0001). In addition, LV fractional shortening (FS) did not change (1.2%; P = NS) whereas the cardiac index increased (6.4%; P = .0007) due to a modest tachycardia accompanied by a reduction in total peripheral resistance (-22.1%; P < .0001). The magnitude of the reduction of LV mass was related to the degree of FS increase (r = -0.70; P < .0001), an indication of beneficial LV remodeling. It can be concluded that isradipine antihypertensive therapy leads to regression of LV hypertrophy without depression of LV pump function.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004452 Echocardiography Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic. Echocardiography, Contrast,Echocardiography, Cross-Sectional,Echocardiography, M-Mode,Echocardiography, Transthoracic,Echocardiography, Two-Dimensional,Transthoracic Echocardiography,2-D Echocardiography,2D Echocardiography,Contrast Echocardiography,Cross-Sectional Echocardiography,Echocardiography, 2-D,Echocardiography, 2D,M-Mode Echocardiography,Two-Dimensional Echocardiography,2 D Echocardiography,Cross Sectional Echocardiography,Echocardiography, 2 D,Echocardiography, Cross Sectional,Echocardiography, M Mode,Echocardiography, Two Dimensional,M Mode Echocardiography,Two Dimensional Echocardiography
D005260 Female Females
D006352 Heart Ventricles The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation. Cardiac Ventricle,Cardiac Ventricles,Heart Ventricle,Left Ventricle,Right Ventricle,Left Ventricles,Right Ventricles,Ventricle, Cardiac,Ventricle, Heart,Ventricle, Left,Ventricle, Right,Ventricles, Cardiac,Ventricles, Heart,Ventricles, Left,Ventricles, Right
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016277 Ventricular Function, Left The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance. Left Ventricular Function,Function, Left Ventricular,Functions, Left Ventricular,Left Ventricular Functions,Ventricular Functions, Left
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
September 1998, Therapeutische Umschau. Revue therapeutique,
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
January 2007, Pediatric nephrology (Berlin, Germany),
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
November 1990, Presse medicale (Paris, France : 1983),
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
January 1992, The Clinical investigator,
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
August 2006, Acta cardiologica,
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
March 1993, American journal of hypertension,
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
January 1979, British journal of clinical pharmacology,
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
July 2008, Hypertension (Dallas, Tex. : 1979),
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
December 2003, Blood pressure. Supplement,
G P Vyssoulis, and E A Karpanou, and C E Pitsavos, and D K Soulas, and P K Toutouzas
August 1992, American family physician,
Copied contents to your clipboard!